Supplementary Methods
In vitro PBP1b transglycosylase assays
For IC 50 determinations, assays were carried out by separately incubating [ 14 C]GlcNAclabeled heptaprenyl lipid II analogue (final concentration = 4 μM, typical specific activity = 288 μCi/μmol) and peptide inhibitors (concentrations are indicated in the figure legends) in lowbinding microcentrifuge tubes (VWR) containing 9 μL of buffer consisting of 50 mM HEPES (pH 7.5), 10 mM CaCl 2 , 1,000 units/mL penicillin G, 0.2 mM octaethylene glycol monodecyl ether (decyl-PEG; Anatrace, Maumee, OH), and 11% DMSO (v/v) for 30 min at room temperature prior to PBP1b addition (to allow binding to occur). Reactions were started by adding 1 μL of PBP1b (from a solution freshly prepared by diluting the 50% glycerol stock 20-fold into PBP1b dilution buffer consisting of 5 mM Tris (pH 8.0), 8 mM decyl-PEG) to the reaction mixture (final PBP1b concentration = 20-100 nM). Reactions were typically stopped after 30-45 min by adding 10 μL of ice-cold 10 mM Tris (pH 8.0) containing 10% Triton X-100.
Quenched reactions were stored on ice until they were spotted on cellulose chromatography paper strips (3MM Whatman chromatography paper #3030-861, cut 1 cm width x 20 cm height) Products and starting material were separated using chromatography (isobutyric acid/1 M NH 4 OH, 5:3). The lipid II starting material migrates on the strip, while polymerized product remains at the origin. The paper strips were removed from chromatography chambers, allowed to dry, cut, and added to separate scintillation vials containing EcoLite(+) liquid scintillation fluid (MP Biomedical). Samples were analyzed using a LS6500 scintillation counter (Beckman Coulter). The percent radioactivity of the polymer product was calculated by comparing the amount of radioactivity that remains at the origin (peptidoglycan) to the total amount of radioactivity on the strip.
For kinetics assays, reactions were carried out by separately incubating various concentrations (indicated in the figure legends) of [
14 C]GlcNAc-labeled heptaprenyl lipid II analogue (typical specific activity = 273 cpm/pmol) and Halα inhibitor (at 0, 6, or 8 μM) in lowbinding microcentrifuge tubes (VWR) containing 9 μL of buffer consisting of 50 mM HEPES (pH 7.5), 10 mM CaCl 2 , 1,000 units/mL penicillin G, 0.2 mM decyl-PEG, and 11% DMSO (v/v) for 30 min at room temperature prior to PBP1b addition (to allow binding to occur). Reactions were started by adding 1 μL of PBP1b (from a solution freshly prepared by diluting the 50% glycerol stock 20-fold into PBP1b dilution buffer consisting of 5 mM Tris (pH 8.0), 8 mM decyl-PEG) to the reaction mixture (final PBP1b concentration = 20-100 nM). Reactions were typically stopped after 15 min by adding 10 μL of ice-cold 10 mM Tris (pH 8.0) containing 10% Triton X-100. Quenched reactions were stored on ice until analyzed using paper chromatography and scintillation counting as described above. Equation used for fitting: rate = V max *(((0.5
9 This equation generates an estimated K D of 14 nM.
Agar diffusion growth inhibition assays
Solid agar diffusion assays were used to assess antimicrobial activity. An overnight culture of the indicator strain Lactococcus lactis HP was grown in GM17 media (supplemented with 0.5% glucose (v/v) under anaerobic conditions at 30 °C. Ninety-six well agar plates were prepared by combining 20 mL of molten media agar (cooled to 42 °C) with 100 µL of dense overnight culture (approx 10 8 -10 9 CFU mL -1 ). The seeded agar was allowed to solidify at 25 °C in a sterile Nunc OmniTray. An additional 30 mL of cooled molten media was combined with 150 µL of culture and poured over the lower solidified agar layer. A sterile 96-well PCR plate was placed in the molten agar upper layer, which was allowed to solidify at 25 °C. After sufficient solidification, the 96-well PCR plate was removed, and 15 µL of peptide solutions were dispensed into the newly formed wells. For wells containing a single compound, the concentration of the peptide was 50 μM. For wells containing two compounds (i.e. co-treatment with Halβ), the peptides were used at a 1:1 ratio and the concentration of each peptide was 50 μM. Plates were incubated at 30 °C for 15 h and antibacterial activity was qualitatively determined by the presence or absence of growth inhibition.
